Magnetic resonance imaging-derived parameters to predict response to regorafenib in recurrent glioblastoma.

Purpose: Regorafenib is a multikinase inhibitor, approved as a preferred regimen for recurrent glioblastoma (rGB). Although its effects on prolonging survival could seem modest, it is still unclear whether a subset of patients, potentially identifiable by imaging biomarkers, might experience a more...

Descripción completa

Detalles Bibliográficos

Publicado en:	Neuroradiology Vol. 65; no. 10; pp. 1439 - 1446
Autores principales:	Martucci, Matia, Ferranti, Andrea Maurizio, Schimperna, Francesco, Infante, Amato, Magnani, Francesca, Olivi, Alessandro, D'Alessandris, Quintino Giorgio, Gessi, Marco, Chiesa, Silvia, Mazzarella, Ciro, Russo, Rosellina, Giordano, Carolina, Gaudino, Simona
Formato:	research tables/charts Journal Article
Publicado:	Springer Nature Oct2023
Acceso en línea:	Ver este registro en EBSCOhost